Portland, Maine: Animal Health Company ImmuCell Reports Third-Quarter Results, Hosts Conference Call This Morning
ImmuCell Corporation (Nasdaq: ICCC), an animal health biologics company headquartered in Portland, Cumberland County, Maine, on November 12 after market close reported its unaudited financial results for the quarter ended September 30, 2026: product sales rose 46.0 percent year over year to approximately $8.0 million; net income was $953,000, or $0.10 per diluted share, compared with a net loss of $140,000 a year earlier; and gross margin was 44.2 percent, up from 42.9 percent a year earlier.
The company will host a conference call and webcast at 9:00 a.m. Eastern Time on Friday, November 13 to review the results, with a replay available through November 20. The preliminary third-quarter sales results the company disclosed on October 12 remain unchanged, and the company filed its quarterly report on Form 10-Q after the close on November 12.
ImmuCell develops, manufactures and markets products that improve calf health and productivity. The company said the call will be accompanied by a slide presentation, with materials to be posted afterward in the investor relations section of its website.
As a Maine-based publicly traded biotechnology company, ImmuCell's performance draws attention from the local business community, and its calf health products serve livestock markets across the United States. (Source: ImmuCell Corporation)
Source: ImmuCell Corporation
Published by GSM · USA (original Chinese edition)
Photo: 图：缅因州波特兰市滨水区与市中心航拍。Quintin Soloviev 摄，CC BY 4.0，经 Wikimedia Commons。 / Photo: Aerial view of the Portland, Maine waterfront and downtown. By Quintin Soloviev, CC BY 4.0, via Wikimedia Commons.
